StaffFebruary 4, 2020
Kali-Extracts, Inc. (OTC: KALY) said that it has entered into a letter of intent (LOI) under which KALY could receive a $20 million investment to fund its Cannabis Biopharmaceutical Technology. The proposed investment values KALY’s cannabis biopharmaceutical technology at $50 million. The company said in a statement that the confidential terms of the LOI target a […]